Siemens taps Harvard prof to replace interim health care CEO | Personnel Moves

MassDevice.com Personnel Moves

Here are the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.

  • Siemens taps Harvard prof to replace interim health care CEO
    Siemens AG’s (NYSE:SI) healthcare division tapped neuro-radiologist Dr. Gregory Sorenson to replace Randy Hall as CEO of Siemens Healthcare in the U.S. and Canada. Hall has acted as interim CEO since April 2010, when former CEO Michael Reitermann moved to a new role in the company’s diagnostics division. Sorenson, 49, is the co-director of the A.A. Martinos Center for Biomedical Imaging at Mass. General Hospital. The appointment is effective June 1.
    Read more
  • Comparative effectiveness institute names first director
    The controversial Patient-Centered Outcomes Research Institute named healthcare researcher Joe Selby as its first executive director. Selby is a health services researcher who has authored more than 200 peer-reviewed articles. He oversees a staff of more than 550 as director of division research at Kaiser Permanente. As a family physician, clinical epidemiologist, and health services researcher, Selby said he’d like to use his position at the institute to "make a difference in the lives of patients."

    Selby will identify opportunities and issues, and implement programs under the authority of PCORI’s board of governors. A key component of the Patient Protection & Affordable Care Act, the institute is an independent non-profit organization focused on comparative effectiveness research, which examines health outcomes and effectiveness of various medical treatments. The effort has met with much criticism from those who argue that comparative effectiveness research negatively affects patient options by giving preference to one-size-fits-all treatments that fail to consider unique patient circumstances.
    Read more

  • Foundation Medicine names new CEO
    Cambridge-based cancer diagnostics startup Foundation Medicine Inc. appointed former GE Healthcare head Michael Pellini as president and CEO. He replaces founding CEO Alexis Borisy, who will take the role of chairman of the board of directors.
    Read more
  • Welch Allyn president & CEO to join U.S. Commerce Innovation Advisory Board
    U.S. Secretary of Commerce Gary Locke named Julie Shimer, president and CEO of Welch Allyn and a member of the Advanced Medical Technology Assn.’s board, to an Innovation Advisory Board assigned to develop a study of America’s innovative capacity and global economic competitiveness. Over the weekend Shimer was also tapped by New York governor Andrew Cuomo to chair the Empire State Development Corp.
    Read more
  • University of the Sciences board of trustees elects two new members
    The USciences Board of Trustees elected Marvin Samson, CEO of Samson Medical Technologies, as chairman and Richard Howard, CEO of Advanced Pharmacy Services, as vice chairman. The election follows the recent retirement announcement of chairman Dr. Delbert Payne, who was subsequently elected emeritus trustee.
    Read more
  • Stem cell startup iPierian axes top execs
    San Francisco-based stem cell startup iPierian, with high-profile backers including GlaxoSmithKline, Kleiner Perkins Caufield & Byers, Google Ventures and Biogen Idec, terminated several members of the excutive team over the last month. The departures have not been publically announced, but roles have been updated on the company’s website.
    Read more

  • Abiomed board member steps down
    Desmond O’Connell Jr., an Abiomed (NSDQ:ABMD) board member since 1995, announced that he will not stand for reelection at the company’s 2011 stockholders’ meeting.
    Read more
  • Echo Therapeutics appoints new CFO
    Christopher Schnittker joined Echo Therapeutics Inc. (OTC:ECTE) as CFO, taking over from COO Harry Mitchell.
    Read more
  • Angeion announces new CFO and VP of engineering
    Angeion Corp. (NSDQ:ANGN) named Rob Wolf as CFO and Mark Gryzwa as vice president of engineering, effective today. Wolf and Gryzwa report to Angeion president and CEO Phil Smith.
    Read more

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply